Stephen D. Westhoven, President and CEO of New Jersey Resources Corp, filed a Form 4 on November 13, 2026, reporting four transactions in New Jersey Resources common stock that occurred on November 10, 2026, covering the vesting of two separate performance-based equity awards and …
New Jersey Resources Corp SVP and COO of Non-Utility Business Amy Cradic filed a Form 4 on November 13, 2026, reporting three equity transactions dated November 10, 2026, covering a restricted stock unit grant, performance share unit vesting, and tax-related share withholding.
New Jersey Resources Corp SVP and CFO Roberto Bel filed a Form 4 on November 13, 2026, disclosing two equity transactions dated November 10, 2026, covering a restricted stock unit grant and a vested performance share unit award under company plans.
Patrick J. Migliaccio, Senior Vice President and Chief Operating Officer of New Jersey Natural Gas at New Jersey Resources Corp (NYSE:NJR), filed a Form 4 on November 13, 2026, reporting three transactions in NJR Common Stock dated November 10, 2026.
Jacqueline K. Shea, SVP and Chief Information Officer of New Jersey Resources Corp (NYSE:NJR), filed a Form 4 on November 13, 2026, reporting three transactions in NJR Common Stock dated November 10, 2026.
Lori DelGiudice, Senior Vice President of Human Resources at New Jersey Resources Corporation, filed a Form 4 on November 13, 2026, reporting three transactions in common stock dated November 10, 2026, including an RSU grant, a performance share unit vesting, and a tax-withholding disposition.
Christopher T. D'Antuono, Corporate Controller and Principal Accounting Officer of New Jersey Resources Corp (NYSE:NJR), filed a Form 4 on November 13, 2026, disclosing the acquisition of 878 restricted stock units on November 10, 2026.
ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 8 to a beneficial ownership statement with the SEC on November 13, 2026, disclosing a combined holding of 7,119,390 shares of Personalis, Inc. common stock as of September 30, 2026.
ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 12 to Schedule 13G with the SEC on November 13, 2026, disclosing aggregate beneficial ownership of 20,508,004 shares of Cerus Corporation common stock as of September 30, 2026.
ARK Investment Management LLC and Catherine D. Wood filed Amendment No. 14 to Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 10,056,844 shares of CRISPR Therapeutics AG common stock as of September 30, 2026.